Synthesis and biological activity of glycolipids, with a focus on gangliosides and sulfatide analogs.
Ikami
T
T
Drug Discovery Research Department, Sanwa Kagaku Kenkyusho Company Limited, Mie, Japan.
Ishida
H
H
Kiso
M
M
D015703:Antigens, CD / Q000737:chemistry; D002240:Carbohydrate Sequence; D015815:Cell Adhesion Molecules / Q000737:chemistry; D005679:G(M3) Ganglioside / Q000737:chemistry; D005732:Gangliosides / Q000138:chemical synthesis* / Q000737:chemistry; D006017:Glycolipids / Q000138:chemical synthesis*; D007166:Immunosuppressive Agents / Q000737:chemistry; D016256:Lewis X Antigen / Q000031:analogs & derivatives; D008024:Ligands; D008969:Molecular Sequence Data; D009844:Oligosaccharides / Q000138:chemical synthesis; D019087:Selectins; D000080506:Sialyl Lewis X Antigen / Q000031:analogs & derivatives; D013329:Structure-Activity Relationship; D013433:Sulfoglycosphingolipids / Q000138:chemical synthesis*
C086949:6'-sulfated sialyl Lewis x; D015703:Antigens, CD; D015815:Cell Adhesion Molecules; D005679:G(M3) Ganglioside; D005732:Gangliosides; D006017:Glycolipids; D007166:Immunosuppressive Agents; D016256:Lewis X Antigen; D008024:Ligands; D009844:Oligosaccharides; D019087:Selectins; D000080506:Sialyl Lewis X Antigen; D013433:Sulfoglycosphingolipids; C028253:ganglioside, GM4